Literature DB >> 30966822

Sodium-glucose co-transporter 2 inhibitors for the prevention of heart failure in type 2 diabetes: A systematic review and meta-analysis.

Naser Yamani1, Muhammad Shariq Usman2, Tauseef Akhtar1, Kaneez Fatima2, Nisar Asmi1, Muhammad Shahzeb Khan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30966822     DOI： 10.1177/2047487319841936

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  4 in total

Review 1.  Effect of ertugliflozin on glycemic levels, blood pressure and body weight of patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Maryam Zaman; Roha Saeed Memon; Arooba Amjad; Tehlil Rizwan; Jai Kumar; Ibtehaj Ul Haque; Syed Saad Ali; Lin Li; Muhammad Shariq Usman
Journal:  J Diabetes Metab Disord       Date:  2020-09-03

Review 2.  Sodium-Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes.

Authors:  Muhammad Shahzeb Khan; Javed Butler
Journal:  Card Fail Rev       Date:  2019-11-04

3.  Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis.

Authors:  Javed Butler; Muhammad Shariq Usman; Muhammad Shahzeb Khan; Stephen J Greene; Tim Friede; Muthiah Vaduganathan; Gerasimos Filippatos; Andrew J Stewart Coats; Stefan D Anker
Journal:  ESC Heart Fail       Date:  2020-12

4.  Sodium Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Hospitalization in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Ailing Zhang; Xufei Luo; Haiyang Meng; Jian Kang; Guijun Qin; Yaolong Chen; Xiaojian Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-15       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.